Ashley Knable
Nurse Practitioner · Louisville, KYNPI 1851720577
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $82,526 of the $85,814 with a category attached, or 96.2%. AbbVie accounts for 82.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $30,856 and has fallen 66.3% since, to $10,391 in 2025. Among nurse practitioner clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 234 payments — averaging $366.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$71K
- Biohaven Pharmaceutical Holding Company Ltd.$9K
- Biohaven Pharmaceuticals, Inc.$6K
- Pfizer$69
- Lilly USA, LLC$35
- Amgen$21
- plus $14 from 1 others
What the payments were for
- Speaking & faculty fees$82,52696%
- Travel & lodging$4301%
- Food & beverage$2,8573%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 158 | $70,681 |
| Biohaven Pharmaceutical Holding Company Ltd. | 45 | $8,602 |
| Biohaven Pharmaceuticals, Inc. | 22 | $6,392 |
| Pfizer | 5 | $69 |
| Lilly USA, LLC | 2 | $35 |
| Amgen | 1 | $21 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$63,161
- QULIPTA$20,937
- NURTEC ODT$14,159
How this compares
$85,814 in reported general payments places this provider in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 289 | $373,779 |
| Emgality PenGalcanezumab-Gnlm | 251 | $231,857 |
| Nurtec OdtRimegepant Sulfate | 135 | $218,471 |
| QuliptaAtogepant | 125 | $155,150 |
| Aimovig AutoinjectorErenumab-Aooe | 162 | $138,208 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 73 | $67,671 |
| Emgality SyringeGalcanezumab-Gnlm | 15 | $14,654 |
| ZavzpretZavegepant Hcl | 12 | $13,482 |
| Sumatriptan Succinate | 197 | $11,959 |
| Naratriptan Hcl | 92 | $3,441 |
| RizatriptanRizatriptan Benzoate | 131 | $2,811 |
| Gabapentin | 142 | $2,167 |
| Topiramate | 90 | $1,624 |
| Eletriptan HbrEletriptan Hydrobromide | 14 | $971 |
| Acetazolamide ErAcetazolamide | 11 | $708 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $70,681 | $528,930414 claims |
| PfizerNurtec Odt, Zavzpret | $69 | $231,954147 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Louisville
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Christina BenningerLouisville$81K
- Rebecca BraunerLouisville$40K
- Thomas FreelsLouisville$20K
- Christy BakerLouisville$18K
- Blair WagnerLouisville$15K
- Kathryn WestLouisville$13K
- Kimberly RobinsonLouisville$13K
- Mistie TeerLouisville$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.